Silva-Abreu M - Search Results

1

Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders.

Silva-Abreu M, Calpena AC, Espina M, Silva AM, Gimeno A, Egea MA, García ML. Silva-Abreu M, et al. Pharm Res. 2018 Jan 3;35(1):11. doi: 10.1007/s11095-017-2319-8. Pharm Res. 2018. PMID: 29299768 Free article.

2

Human Skin Permeation Studies with PPARγ Agonist to Improve Its Permeability and Efficacy in Inflammatory Processes.

Silva-Abreu M, Espinoza LC, Rodríguez-Lagunas MJ, Fábrega MJ, Espina M, García ML, Calpena AC. Silva-Abreu M, et al. Int J Mol Sci. 2017 Nov 28;18(12):2548. doi: 10.3390/ijms18122548. Int J Mol Sci. 2017. PMID: 29182532 Free PMC article.

3

Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye.

Gonzalez-Pizarro R, Silva-Abreu M, Calpena AC, Egea MA, Espina M, García ML. Gonzalez-Pizarro R, et al. Int J Pharm. 2018 Aug 25;547(1-2):338-346. doi: 10.1016/j.ijpharm.2018.05.050. Epub 2018 May 22. Int J Pharm. 2018. PMID: 29800741

4

PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies.

Silva-Abreu M, Calpena AC, Andrés-Benito P, Aso E, Romero IA, Roig-Carles D, Gromnicova R, Espina M, Ferrer I, García ML, Male D. Silva-Abreu M, et al. Int J Nanomedicine. 2018 Sep 20;13:5577-5590. doi: 10.2147/IJN.S171490. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30271148 Free PMC article.

5

Thiazolidinedione as an alternative to facilitate oral administration in geriatric patients with Alzheimer's disease.

Silva-Abreu M, Gonzalez-Pizarro R, Espinoza LC, Rodríguez-Lagunas MJ, Espina M, García ML, Calpena AC. Silva-Abreu M, et al. Eur J Pharm Sci. 2019 Mar 1;129:173-180. doi: 10.1016/j.ejps.2019.01.008. Epub 2019 Jan 9. Eur J Pharm Sci. 2019. PMID: 30639402

6

Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil.

Espinoza LC, Silva-Abreu M, Clares B, Rodríguez-Lagunas MJ, Halbaut L, Cañas MA, Calpena AC. Espinoza LC, et al. Pharmaceutics. 2019 Feb 1;11(2):64. doi: 10.3390/pharmaceutics11020064. Pharmaceutics. 2019. PMID: 30717264 Free PMC article.

7

Comparative Study of Ex Vivo Transmucosal Permeation of Pioglitazone Nanoparticles for the Treatment of Alzheimer's Disease.

Silva-Abreu M, Espinoza LC, Halbaut L, Espina M, García ML, Calpena AC. Silva-Abreu M, et al. Polymers (Basel). 2018 Mar 14;10(3):316. doi: 10.3390/polym10030316. Polymers (Basel). 2018. PMID: 30966351 Free PMC article.

8

Nanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases.

Espinoza LC, Silva-Abreu M, Calpena AC, Rodríguez-Lagunas MJ, Fábrega MJ, Garduño-Ramírez ML, Clares B. Espinoza LC, et al. Nanomedicine. 2019 Jul;19:115-125. doi: 10.1016/j.nano.2019.03.017. Epub 2019 Apr 18. Nanomedicine. 2019. PMID: 31004811

9

Thermoreversible Gel-Loaded Amphotericin B for the Treatment of Dermal and Vaginal Candidiasis.

Sosa L, Calpena AC, Silva-Abreu M, Espinoza LC, Rincón M, Bozal N, Domenech O, Rodríguez-Lagunas MJ, Clares B. Sosa L, et al. Pharmaceutics. 2019 Jul 3;11(7):312. doi: 10.3390/pharmaceutics11070312. Pharmaceutics. 2019. PMID: 31277267 Free PMC article.

10

Topical Pioglitazone Nanoformulation for the Treatment of Atopic Dermatitis: Design, Characterization and Efficacy in Hairless Mouse Model.

Espinoza LC, Vera-García R, Silva-Abreu M, Domènech Ò, Badia J, Rodríguez-Lagunas MJ, Clares B, Calpena AC. Espinoza LC, et al. Pharmaceutics. 2020 Mar 12;12(3):255. doi: 10.3390/pharmaceutics12030255. Pharmaceutics. 2020. PMID: 32178278 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters